Publication & Citation Trends
Publications
50 total
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer PDF
Cited by 92
OpenAlex
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR–): survival outcomes from a multicentre, open-label, randomised, phase 2 trial
Cited by 77
OpenAlex
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2– Early Breast Cancer
Cited by 89
Semantic Scholar
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial OA
Cited by 10
Semantic Scholar
Abstract GS4-04: Endocrine therapy alone in patients with intermediate or high-risk luminal early breast cancer (0-3 lymph nodes), Recurrence Score <26 and Ki67 response after preoperative endocrine therapy: Primary outcome results from the WSG-ADAPT HR+/HER2- trial
Cited by 15
Semantic Scholar
De-escalated neoadjuvant pertuzumab+trastuzumab with or without paclitaxel weekly in HR-/HER2+ early breast cancer: ADAPT-HR-/HER2+ biomarker and survival results.
Cited by 19
Semantic Scholar
Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12‐week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials OA
Cited by 9
Semantic Scholar
Patient‐reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2–positive breast cancer PDF
Cited by 26
OpenAlex
Research Topics
HER2/EGFR in Cancer Research
(41)
Lung Cancer Treatments and Mutations
(28)
Breast Cancer Treatment Studies
(16)
Medical Imaging Techniques and Applications
(12)
Monoclonal and Polyclonal Antibodies Research
(11)
Affiliations
Goethe University Frankfurt
Heidelberg University
University Hospital Heidelberg
Evangelisches Krankenhaus Oberhausen
Breast Center